Gene delivery with active targeting to ovarian cancer cells mediated by folate receptor α

Journal of Biomedical Nanotechnology

Volumn 9, Issue 5, 2013, Pages 833-844

  He, Zhiyao ^a   Yu, Yiyi ^b   Zhang, Ying ^c   Yan, Yongdong ^a   Zheng, Yu ^a   He, Jun ^a   Xie, Yongmei ^a   He, Gu ^a   Wei, Yuquan ^a   Song, Xiangrong ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

Cationic Liposome; Folate; Folate Receptor ; Gene Delivery; Lipoplex; Ovarian Cancer

Indexed keywords

CATIONIC LIPOSOMES; FOLATE; FOLATE RECEPTOR; GENE DELIVERY; LIPOPLEXES; OVARIAN CANCERS;

CELL CULTURE; CELLS; COMPLEXATION; DISEASES; GENES; LIPOSOMES; ORGANIC ACIDS; POLYETHYLENE GLYCOLS; SYNTHESIS (CHEMICAL); TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

GENE TRANSFER;

CHOLESTEROL; FOLATE MODIFIED CATIONIC LIPOSOME; FOLATE POLY(ETHYLENE GLYCOL) SUCCINATE CHOLESTEROL; FOLATE RECEPTOR 1; LIPOSOME; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CYTOTOXICITY; GENE TARGETING; GENE THERAPY; GENETIC TRANSFECTION; OVARY CANCER; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

ANTINEOPLASTIC AGENTS; CHOLESTEROL; FEMALE; FOLATE RECEPTOR 1; FOLIC ACID; GENE TRANSFER TECHNIQUES; HEP G2 CELLS; HUMANS; KB CELLS; LIPOSOMES; MODELS, BIOLOGICAL; MOLECULAR TARGETED THERAPY; OVARIAN NEOPLASMS; POLYETHYLENE GLYCOLS; SUCCINIC ACID; TUMOR CELLS, CULTURED;

EID: 84877785323     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2013.1587     Document Type: Article

References (32)

1. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, Global cancer statistics. CA Cancer J. Clin. 61, 69 (2011).
2. S. Westin, T. Herzog, and R. Coleman, Investigational agents in development for the treatment of ovarian cancer. Invest. New Drugs Online First™ (2012).
3. L. Crane, H. Arts, M. van Oosten, P. Low, A. van der Zee, G. van Dam, and J. Bart, The effect of chemotherapy on expression of folate receptor-alpha in ovarian cancer. Cell Oncol. 35, 9 (2012).
4. Y.-L. Chen, M.-C. Chang, C.-Y. Huang, Y.-C. Chiang, H.-W. Lin, C.-A. Chen, C.-Y. Hsieh, and W.-F. Cheng, Serous ovarian carcinoma patients with high alpha-folate receptor had reducing survival and cytotoxic chemo-response. Mol. Oncol. 6, 360 (2012).
5. D. H. Suh, K. Kim, and J. W. Kim, Major clinical research advances in gynecologic cancer in 2011. J. Gynecol. Oncol. 23, 53 (2012).
6. L. Teng, J. Xie, L. Teng, and R. J. Lee, Clinical translation of folate receptor-targeted therapeutics. Expert Opin. Drug Deliv. 0, 1 (2012).
7. J. A. Rakowski, S. Ahmad, and R. W. Holloway, Use of pegylated liposomal doxorubicin in the management of platinum-sensitive recurrent ovarian cancer: Current concepts. Expert Rev. Anticancer Ther. 12, 31 (2012).
8. A. Chaudhury, S. Das, R. M. Bunte, and G. N. Chiu, Potent therapeutic activity of folate receptor-targeted liposomal carboplatin in the localized treatment of intraperitoneally grown human ovarian tumor xenograft. Int. J. Nanomedicine 7, 739 (2012).
9. M. E. Werner, S. Karve, R. Sukumar, N. D. Cummings, J. A. Copp, R. C. Chen, T. Zhang, and A. Z. Wang, Folate-targeted nanoparticle delivery of chemo- and radiotherapeutics for the treatment of ovarian cancer peritoneal metastasis. Biomaterials 32, 8548 (2011).
10. C. R. Patra, R. Bhattacharya, D. Mukhopadhyay, and P. Mukherjee, Application of gold nanoparticles for targeted therapy in cancer. J. Biomed. Nanotechnol. 4, 99 (2008).
11. M. Stevanovic, A. Radulovic, B. Jordovic, and D. Uskokovic, Poly(DL-lactide-co-glycolide) nanospheres for the sustained release of folic acid. J. Biomed. Nanotechnol. 4, 349 (2008).
12. Y. Hattori, H. Kubo, K. Higashiyama, and Y. Maitani, Folate-linked nanoparticles formed with DNA complexes in sodium chloride solution enhance transfection efficiency. J. Biomed. Nanotechnol. 1, 176 (2005).
13. M. Sharma, R. Malik, A. Verma, P. Dwivedi, G. S. Banoth, N. Pandey, J. Sarkar, P. R. Mishra, and A. K. Dwivedi, Folic acid conjugated guar gum nanoparticles for targeting methotrexate to colon cancer. J. Biomed. Nanotechnol. 9, 96 (2013).
14. J. Li, Z. He, S. Yu, S. Li, Q. Ma, Y. Yu, J. Zhang, R. Li, Y. Zheng, G. He, and X. Song, Micelles based on methoxy poly(ethylene glycol) cholesterol conjugate for controlled and targeted drug delivery of a poorly water soluble drug. J. Biomed. Nanotechnol. 8, 809 (2012).
15. G. Xiang, J. Wu, Y. Lu, Z. Liu, and R. J. Lee, Synthesis and evaluation of a novel ligand for folate-mediated targeting liposomes. Int. J. Pharm. 356, 29 (2008).
16. Z. Y. He, X. Zheng, X. H. Wu, X. R. Song, G. He, W. F. Wu, S. Yu, S. J. Mao, and Y. Q. Wei, Development of glycyrrhetinic acid-modified stealth cationic liposomes for gene delivery. Int. J. Pharm. 397, 147 (2010).
17. I. Moret, J. E. Peris, V. M. Guillem, M. Benet, F. Revert, F. Dasl, A. Crespo, and S. F. Aliño, Stability of PEI-DNA and DOTAP-DNA complexes: Effect of alkaline pH, heparin and serum. J. Control Release 76, 169 (2001).
18. S. Shi, Q. Guo, B. Kan, S. Fu, X. Wang, C. Gong, H. Deng, F. Luo, X. Zhao, Y. Wei, and Z. Qian, A novel poly(epsiloncaprolactone)- pluronic-poly(epsilon-caprolactone) grafted polyethyleneimine (PCFC-g-PEI), Part 1, synthesis, cytotoxicity, and in vitro transfection study. BMC Biotechnol. 9, 65 (2009).
19. G. Zhai, J. Wu, G. Xiang, W. Mao, B. Yu, H. Li, L. Piao, L. J. Lee, and R. J. Lee, Preparation, characterization and pharmacokinetics of folate receptor-targeted liposomes for docetaxel delivery. J. Nanosci. Nanotechnol. 9, 2155 (2009).
20. X. R. Song, Y. Zheng, G. He, L. Yang, Y. F. Luo, Z. Y. He, S. Z. Li, J. M. Li, S. Yu, X. Luo, S. X. Hou, and Y. Q. Wei, Development of PLGA nanoparticles simultaneously loaded with vincristine and verapamil for treatment of hepatocellular carcinoma. J. Pharm. Sci. 99, 4874 (2010).
21. W. L. J. Hinrichs, N. N. Sanders, S. C. De Smedt, J. Demeester, and H. W. Frijlink, Inulin is a promising cryo- and lyoprotectant for PEGylated lipoplexes. J. Control Release 103, 465 (2005).
22. J. H. van Steenis, E. M. van Maarseveen, F. J. Verbaan, R. Verrijk, D. J. A. Crommelin, G. Storm, and W. E. Hennink, Preparation and characterization of folate-targeted pEG-coated pDMAEMA-based polyplexes. J. Control Release 87, 167 (2003).
23. C. Tros de Ilarduya, Y. Sun, and N. Düzgünȩs, Gene delivery by lipoplexes and polyplexes. Eur. J. Pharm. Biopharm. 40, 159 (2010).
24. J. A. Reddy, C. Abburi, H. Hofland, S. J. Howard, I. Vlahov, P. Wils, and C. Leamon, Folate-targeted, cationic liposome-mediated gene transfer into disseminated peritoneal tumors. Gene Therapy 9, 1542 (2002).
25. J. A. Reddy, D. Dean, M. D. Kennedy, and P. S. Low, Optimization of folate-conjugated liposomal vectors for folate receptor-mediated gene therapy. J. Pharm. Sci. 88, 1112 (1999).
26. X. Han, J. Liu, M. Liu, C. Xie, C. Y. Zhan, B. Gu, Y. Liu, L. L. Feng, and W. Y. Lu, 9-NC-loaded folate-conjugated polymer micelles as tumor targeted drug delivery system: Preparation and evaluation in vitro. Int. J. Pharm. 372, 125 (2009).
27. H. Lee, A. K. R. Lytton-Jean, Y. Chen, K. T. Love, A. I. Park, E. D. Karagiannis, A. Sehgal, W. Querbes, C. S. Zurenko, M. Jayaraman, C. G. Peng, K. Charisse, A. Borodovsky, M. Manoharan, J. S. Donahoe, J. Truelove, M. Nahrendorf, R. Langer, and D. G. Anderson, Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery. Nat. Nanotechnol. 7, 389 (2012).
28. N. S. Templeton, Cationic liposomes as in vivo delivery vehicles. Curr. Med. Chem. 10, 1279 (2003).
29. S. Dabbas, R. R. Kaushik, S. Dandamudi, G. M. Kuesters, and R. B. Campbell, Importance of the liposomal cationic lipid content and type in tumor vascular targeting: Physicochemical characterization and in vitro studies using human primary and transformed endothelial cells. Endothelium 15, 189 (2008).
30. T. Hagigit, T. Nassar, F. Behar-Cohen, G. Lambert, and S. Benita, The influence of cationic lipid type on in-vitro release kinetic profiles of antisense oligonucleotide from cationic nanoemulsions. Eur. J. Pharm. Biopharm. 70, 248 (2008).
31. M. Morille, C. Passirani, E. Letrou-Bonneval, J. P. Benoit, and B. Pitard, Galactosylated DNA lipid nanocapsules for efficient hepatocyte targeting. Int. J. Pharm. 379, 293 (2009).
32. H. Elnakat and M. Ratnam, Distribution, functionality and gene regulation of folate receptor isoforms: Implications in targeted therapy. Adv. Drug Deliv. Rev. 56, 1067 (2004).